ADPT Adaptive Biotechnologies Corp

Price (delayed)

$62.14

Market cap

$8.5B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.82

Enterprise value

$8.05B

Sector: Healthcare
Industry: Biotechnology

Highlights

ADPT's equity is up by 46% since the previous quarter and by 32% year-on-year
The quick ratio is up by 36% since the previous quarter and by 6% year-on-year
ADPT's EPS has surged by 78% year-on-year but it is down by 24% since the previous quarter
The company's net income has shrunk by 100% YoY and by 23% QoQ
ADPT's debt has surged by 98% year-on-year

Key stats

What are the main financial stats of ADPT
Market
Shares outstanding
136.77M
Market cap
$8.5B
Enterprise value
$8.05B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10.89
Price to sales (P/S)
90.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
87.07
Earnings
Revenue
$92.41M
EBIT
-$123.38M
EBITDA
-$112.97M
Free cash flow
-$148.48M
Per share
EPS
-$0.82
Free cash flow per share
-$1.1
Book value per share
$5.71
Revenue per share
$0.69
TBVPS
$7.19
Balance sheet
Total assets
$1.1B
Total liabilities
$320.43M
Debt
$46.34M
Equity
$775.05M
Working capital
$776.53M
Liquidity
Debt to equity
0.06
Current ratio
8.7
Quick ratio
8.42
Net debt/EBITDA
4.01
Margins
EBITDA margin
-122.3%
Gross margin
75.9%
Net margin
-132.3%
Operating margin
-143.7%
Efficiency
Return on assets
-13.1%
Return on equity
-20.1%
Return on invested capital
-26.6%
Return on capital employed
-12.4%
Return on sales
-133.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ADPT stock price

How has the Adaptive Biotechnologies stock price performed over time
Intraday
-5.14%
1 week
-7.72%
1 month
-0.62%
1 year
103.4%
YTD
5.09%
QTD
5.09%

Financial performance

How have Adaptive Biotechnologies's revenue and profit performed over time
Revenue
$92.41M
Gross profit
$70.15M
Operating income
-$132.77M
Net income
-$122.27M
Gross margin
75.9%
Net margin
-132.3%
The company's net income has shrunk by 100% YoY and by 23% QoQ
Adaptive Biotechnologies's operating income has shrunk by 94% YoY and by 17% QoQ
ADPT's net margin has dropped by 69% year-on-year and by 23% since the previous quarter
Adaptive Biotechnologies's operating margin has shrunk by 64% YoY and by 16% QoQ

Growth

What is Adaptive Biotechnologies's growth rate over time

Valuation

What is Adaptive Biotechnologies stock price valuation
P/E
N/A
P/B
10.89
P/S
90.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
87.07
ADPT's EPS has surged by 78% year-on-year but it is down by 24% since the previous quarter
ADPT's equity is up by 46% since the previous quarter and by 32% year-on-year
ADPT's P/B is 33% above its last 4 quarters average of 8.2
ADPT's price to sales (P/S) is 81% higher than its last 4 quarters average of 49.9
The revenue has grown by 18% YoY

Efficiency

How efficient is Adaptive Biotechnologies business performance
The ROIC has plunged by 186% YoY and by 38% from the previous quarter
Adaptive Biotechnologies's ROA has plunged by 93% YoY and by 17% from the previous quarter
The ROE has shrunk by 90% YoY and by 13% QoQ
ADPT's return on sales has dropped by 70% year-on-year and by 21% since the previous quarter

Dividends

What is ADPT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADPT.

Financial health

How did Adaptive Biotechnologies financials performed over time
The quick ratio is up by 36% since the previous quarter and by 6% year-on-year
The current ratio has grown by 36% from the previous quarter and by 6% YoY
ADPT's debt is 94% smaller than its equity
ADPT's debt to equity has surged by 50% year-on-year but it is down by 33% since the previous quarter
ADPT's equity is up by 46% since the previous quarter and by 32% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.